Seller comparison · US self-pay prices

Noom vs MEDVi: Which Is Cheaper? GLP-1 Prices Compared

Last updated

Each seller's lowest price now

  • Lowest price, compounded and not FDA-approved

    Noom

    $279/28 days · about $299 per 30 days · 3-month plan

  • Lowest price, compounded and not FDA-approved

    MEDVi

    $199/mo

The same medicine for less than Noom and MEDVi, at sellers we link to

  • Compounded semaglutide, not FDA-approved

    Eden

    $99/mo · about $107 less per 30 days than MEDVi

  • Compounded tirzepatide, not FDA-approved

    Eden

    $129/mo · about $182 less per 30 days than MEDVi

They pay us if you buy, which never changes a price we show.

Noom and MEDVi both sell compounded semaglutide injection. Compounded semaglutide injection: about $86 less per 30 days at MEDVi: $199/mo (≈ $213 per 30 days, its month read as four weekly doses), against ≈ $299 per 30 days at Noom. Only MEDVi has a listed price for compounded tirzepatide injection here. Both list only compounded GLP-1s here. Compounded GLP-1s are not FDA-approved. Prices checked Nov 11, 2026 and Nov 13, 2026.

Every cash quote was checked on or after . Each quote shows its own check date. A quoted price is not a recommendation of a seller, a product or a dose. How we source prices

Same product

What Noom and MEDVi charge for the same medication

Entry prices first, then the published top-dose price where either seller states one. Each price names the seller's own page it was read from.

Compounded semaglutide injection

Entry price: about $86 less per 30 days at MEDVi: $199/mo (≈ $213 per 30 days, its month read as four weekly doses), against ≈ $299 per 30 days at Noom.

Noom

Advertised entry price

$279/28 days (noom.com/med/glp-1rx)

28-day supply · 3-month upfront payment required (noom.com)

≈ $298.93 per 30 days at this quoted rate

Checked on noom.com

Compounded semaglutide via Noom Med

Noom · seller's own price

after $129 for the first 4-week supply; billed $837 every 12 weeks; medication (if prescribed), clinician visits, coaching and the Noom program included

Price conditions

after $129 for the first 4-week supply; billed $837 every 12 weeks; medication (if prescribed), clinician visits, coaching and the Noom program included

Noom states $279/month, billed as $837 for 12 weeks; an FAQ on the same page still says $249/mo on the recurring 12-week plan. Cancel anytime. Not available in Alabama, Louisiana or Mississippi. Compounded; not FDA-approved.

28-day supply · 3-month upfront payment required

MEDVi

Advertised entry price

$199/mo (glp1.medvi.org)

Billed per month; days of supply not on record, so ordered as four weekly doses.

Checked on glp1.medvi.org

Compounded semaglutide via MEDVi

MEDVi · seller's own price

refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract

Price conditions

refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract

Weekly injection. Another MEDVi landing page shows semaglutide at $116 a month in one place and $166 a month in its FAQ. MEDVi also sells a daily GLP-1 tablet from $249 without naming the drug. Compounded; not FDA-approved.

Listed by one of them

What only one of them lists

Noom

Everything Noom sells here is also sold by the other seller (above).

MEDVi
  • Compounded tirzepatide injection

    Advertised entry price

    $299/mo (glp1.medvi.org/results/cv-tirz)

    28-day supply (glp1.medvi.org)

    ≈ $320.36 per 30 days at this quoted rate

    Checked on glp1.medvi.org

    Compounded tirzepatide via MEDVi

    MEDVi · seller's own price

    monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)

    Price conditions

    monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)

    Weekly injection. Another MEDVi landing page shows tirzepatide at $166 a month, and $199 a month in its FAQ. Multi-month packages are not refunded for unused months. Compounded; not FDA-approved.

    28-day supply

    Published maintenance dose

    $299/mo (glp1.medvi.org/results/cv-tirz)

    28-day supply (glp1.medvi.org)

    ≈ $320.36 per 30 days at this quoted rate

    Checked on glp1.medvi.org

    At 15 mg

    Compounded tirzepatide via MEDVi

    MEDVi · seller's own price

    monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)

    Price conditions

    monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)

    Weekly injection. Another MEDVi landing page shows tirzepatide at $166 a month, and $199 a month in its FAQ. Multi-month packages are not refunded for unused months. Compounded; not FDA-approved.

    The seller states one price at every dose, so this is also its price at 15 mg.

    28-day supply

Same medication, lower price

Cheaper than Noom and MEDVi

Other sellers' current prices for the same product, below the lower of these two, compared per 30 days where both state their supply. Compounded medication is compared only with compounded, and an FDA-approved product only with itself.

Compounded, not FDA-approved

Compounded semaglutide

Lower than both. MEDVi: $199/mo, checked Nov 11, 2026 on glp1.medvi.org.

  1. Collective: $59/mo + $199/yr membership. Checked Nov 15, 2026 on collective.org.View offer
  2. Sunlight: $78/mo, about $84 per 30 days. Checked Nov 11, 2026 on sunlight.com.View offer
  3. Avono Health: $79/mo. Checked Nov 13, 2026 on avonohealth.com.View offer
  4. Embody: $79/mo. Checked Nov 14, 2026 on joinem.co.View offer

Compounded, not FDA-approved

Compounded tirzepatide

Lower than MEDVi. MEDVi: $299/mo, checked Nov 13, 2026 on glp1.medvi.org.

  1. Collective: $69/mo + $199/yr membership. Checked Nov 15, 2026 on collective.org.View offer
  2. FlatRx: $118/mo. Checked Nov 17, 2026 on flatrx.io.View offer
  3. Arbor: $119/mo. Checked Nov 13, 2026 on startarbor.com.View offer
  4. Mint Med: $119/mo. Checked Nov 11, 2026 on mintmed.com.View offer

Compounded GLP-1s are not FDA-approved. Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality before they are marketed. FDA: concerns with unapproved GLP-1 drugs used for weight loss (fda.gov)

Questions

Noom vs MEDVi: common questions

Is Noom or MEDVi cheaper for GLP-1 medication?

Compounded semaglutide injection: about $86 less per 30 days at MEDVi: $199/mo (≈ $213 per 30 days, its month read as four weekly doses), against ≈ $299 per 30 days at Noom. Only MEDVi: Compounded tirzepatide injection $299/mo. Prices are the sellers' own advertised self-pay prices, with the conditions listed beside each.

Do Noom and MEDVi sell FDA-approved GLP-1s or compounded versions?

Both list only compounded GLP-1s here. Compounded GLP-1s are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality.

What do Noom and MEDVi prices include?

Noom, compounded semaglutide injection: $279/28 days, after $129 for the first 4-week supply; billed $837 every 12 weeks; medication (if prescribed), clinician visits, coaching and the Noom program included. MEDVi, compounded semaglutide injection: $199/mo, refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract. MEDVi, compounded tirzepatide injection: $299/mo, monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months).

When were Noom and MEDVi prices last checked?

Prices checked Nov 11, 2026 and Nov 13, 2026. Each quote names the seller's own page it was read from. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.

Every sourced offer

All Noom and MEDVi offers

Both sellers' quotes in one table, lowest 30-day cost first where the seller states its supply.

3 current prices

Lowest starting 30-day cost ·

  • View
    $199/mo (glp1.medvi.org)

    Checked on glp1.medvi.org

    Top dose: No separate price on record

    Terms & source

    Advertised price: refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract

    Billed per month; days of supply not on record, so ordered as four weekly doses.

    Weekly injection. Another MEDVi landing page shows semaglutide at $116 a month in one place and $166 a month in its FAQ. MEDVi also sells a daily GLP-1 tablet from $249 without naming the drug. Compounded; not FDA-approved.

    Partner: This seller may pay us a referral fee if you buy through our link, at no extra cost to you. That moves it up in our default order, never in a lowest-cost sort, and is not a medical recommendation.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (glp1.medvi.org)
  • View
    $279/28 days (noom.com/med/glp-1rx)

    3-month plan

    3-month upfront payment required

    ≈ $298.93 per 30 days

    Checked on noom.com

    Top dose: No separate price on record

    Terms & source

    Advertised price: after $129 for the first 4-week supply; billed $837 every 12 weeks; medication (if prescribed), clinician visits, coaching and the Noom program included

    28-day supply · 3-month upfront payment required (noom.com)

    ≈ $298.93 per 30 days at this quoted rate

    Noom states $279/month, billed as $837 for 12 weeks; an FAQ on the same page still says $249/mo on the recurring 12-week plan. Cancel anytime. Not available in Alabama, Louisiana or Mississippi. Compounded; not FDA-approved.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (noom.com)
  • View
    $299/mo (glp1.medvi.org/results/cv-tirz)

    ≈ $320.36 per 30 days

    Checked on glp1.medvi.org

    Top dose: same price at 15 mg

    Terms & source

    Advertised price: monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)

    28-day supply (glp1.medvi.org)

    ≈ $320.36 per 30 days at this quoted rate

    Other plan lengths

    • $193/mo on 3 months
    • $183/mo on 6 months
    • $166/mo on 12 months

    Top-dose terms: The seller states one price at every dose, so this is also its price at 15 mg.

    Weekly injection. Another MEDVi landing page shows tirzepatide at $166 a month, and $199 a month in its FAQ. Multi-month packages are not refunded for unused months. Compounded; not FDA-approved.

    Partner: This seller may pay us a referral fee if you buy through our link, at no extra cost to you. That moves it up in our default order, never in a lowest-cost sort, and is not a medical recommendation.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (glp1.medvi.org)
  • Zepbound

    Noom

    Check price

    No current cited price verified

    Top dose: No separate price on record

    Terms & source

    Advertised price: its access page says "Noom provides access to FDA-approved GLP-1 medications at the lowest published prices. These include Wegovy® pill, Wegovy®, Zepbound®, and Foundayo®." and states no Zepbound price of its own

    Its GLP-1Rx page also lists Zepbound and Mounjaro as tirzepatide options with get-started buttons and no price. FDA-approved product.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (noom.com)

Read prices in context. Compare the same product, dose and payment terms; missing prices are not estimated. Compounded medicines are not FDA-approved.

How this list is ordered. Some sellers may pay us a referral fee, as their terms say. In this sort they are not moved up, and it never changes what you pay.

How prices are compared, what FDA says about compounding and how we earn

A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes, converted to 30 days: by the supply a price buys where the seller states it in days, otherwise a monthly price with its plan length on record read as four weekly doses, a yearly membership in the price spread over twelve months. Introductory prices, ranges, prices with no plan length on record and separately billed fees are unranked references. Dose changes and added fees affect what you pay.

A listed maintenance dose is not a dosing recommendation.

FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved (fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize). Its conditions for a pharmacy compounding them now include "The drug product is compounded for an individual patient based on receipt of a prescription" and "The compounder does not compound, regularly or in inordinate amounts, any that are essentially copies of a commercially available drug product." (fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize) In May 2026 FDA proposed leaving semaglutide, tirzepatide and liraglutide off the 503B Bulks List (federalregister.gov/documents/2026/05/01/2026-08552/list-of-bulk-drug-substances-for-which-there-is-a-clinical-need-under-section-503b-of-the-federal), the ingredients outsourcing facilities may compound from; comments closed Jul 30, 2026 (govinfo.gov/content/pkg/FR-2026-06-26/html/2026-12937.htm), and we found no final notice when we last read the Federal Register (Nov 6, 2026). FDA's newest warning letter to a pharmacy over compounded semaglutide or tirzepatide went to Empower Clinic Services, LLC dba Empower Pharmacy (fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/empower-clinic-services-llc-dba-empower-pharmacy-738238-09182026) on Sep 18, 2026 (every GLP-1 warning letter). FDA's newest recall report of a compounded semaglutide or tirzepatide product is Houston Rx LLC's tirzepatide (api.fda.gov/drug/enforcement.json), reported Oct 21, 2026: "Lack of assurance of sterility." (every tirzepatide recall). Liraglutide is different: FDA's shortage database (accessdata.fda.gov/scripts/drugshortages) still lists it in shortage (updated at source Oct 14, 2026; every GLP-1 shortage). FDA: "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed." (fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers) A low price is not a low-risk signal; confirm current terms with the provider.

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

Public record

Noom vs MEDVi: reviews, BBB and FDA

What Trustpilot, the BBB and the FDA say about each. These records do not measure medical quality or results.

Noom

Trustpilot 4.5 from 67,221 reviews. The BBB rates Noom A+, with 597 complaints filed in the last 3 years. It is BBB accredited. We found no FDA warning letter naming Noom as of Nov 6, 2026.

Is Noom legit?

MEDVi

Trustpilot 4.3 from 15,227 reviews. The BBB rates MEDVi F, with 789 complaints filed in the last 3 years. It is not BBB accredited. The FDA sent MEDVi a warning letter (Feb 20, 2026) about claims on its website. The words that letter quotes ("Same active ingredient as Wegovy® and Ozempic®") were on none of the 3 pages of home.medvi.org and glp1.medvi.org we read on Nov 16, 2026.

Is MEDVi legit?

Seller pages re-read automatically : 3 of 4 opened and checked for price changes. How prices stay current

Updated automatically

Noom and MEDVi price changes

  • Seller recordMEDVi: updated record on its public ratings and records
  • Seller recordNoom: record on testing its compounded medicine removed
  • PriceMEDVi: Compounded tirzepatide via MEDVi now ranked per 30 days at about $320: $299/mo buys 28 days (read on glp1.medvi.org)
  • Seller recordMEDVi: updated record on who makes its medicine (read on home.medvi.org)
  • Seller recordNoom: updated record on who makes its medicine (read on noom.com)
  • Seller recordNoom: updated record on its public ratings and records

Written from each source's own record as it changes. Every change on GLPcompare

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.